Abstract:Cancer-associated fibroblasts (CAFs) found in primary and metastatic tumours are highly versatile, plastic and resilient cells that are actively involved in cancer progression through complex interactions with other cell types in the tumour microenvironment. As well as generating extracellular matrix components that contribute to the structure and function of the tumour stroma, CAFs undergo epigenetic changes to produce secreted factors, exosomes and metabolites that influence tumour angiogenesis, immunology and metabolism. Because of their putative pro-oncogenic functions, CAFs have long been considered an attractive therapeutic target; however, clinical trials of treatment strategies targeting CAFs have mostly ended in failure and, in some cases, accelerated cancer progression and resulted in inferior survival outcomes. Importantly, CAFs are heterogeneous cells and their characteristics and interactions with other cell types might change dynamically as cancers evolve. Studies involving single-cell RNA sequencing and novel mouse models have increased our understanding of CAF diversity, although the context-dependent roles of different CAF populations and their interchangeable plasticity remain largely unknown. Comprehensive characterization of the tumour-promoting and tumour-restraining activities of CAF subtypes, including how these complex bimodal functions evolve and are subjugated by neoplastic cells during cancer progression, might facilitate the development of novel diagnostic and therapeutic approaches. In this Review, the clinical relevance of CAFs is summarized with an emphasis on their value as prognosis factors and therapeutic targets. Cancer-associated fibroblasts (CAFs) are inherently linked with cancers and have long been considered attractive therapeutic targets. However, the existence of several CAF subpopulations with substantial phenotypic and functional heterogeneity and plasticity is increasingly recognized. This Review provides an overview of the heterogeneity of CAFs and its implications with regard to the tumour-promoting and tumour-restraining roles of these cells as well as their clinical relevance in terms of prognostic value and therapeutic potential. The authors also provide insights and perspectives on future research and clinical studies involving CAFs.

Tumor-associated fibroblasts predominantly come from local and not circulating precursors

Tangled Fibroblasts in Tumor‐stroma Interactions

Activated Tumor-infiltrating Fibroblasts Predict Worse Prognosis in Breast Cancer Patients

Cancer‐associated Fibroblasts in Breast Cancer: Challenges and Opportunities

Cancer-Associated Fibroblasts Suppress Cancer Development: The Other Side of the Coin

Fibroblasts in the Tumor Microenvironment: Shield or Spear?

Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities

DIVERSITY AND BIOLOGY OF CANCER-ASSOCIATED FIBROBLASTS.

Cancer-Associated Fibroblast Heterogeneity and Its Influence on the Extracellular Matrix and the Tumor Microenvironment

A peek into cancer-associated fibroblasts: origins, functions and translational impact

Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model

Cancer Associated Fibroblasts: an Essential Role in the Tumor Microenvironment

Fibroblasts in cancer: Unity in heterogeneity

Cancer-associated fibroblasts: from basic science to anticancer therapy

Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth

Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets

Evidence of steady-state fibroblast subtypes in the normal human breast as cells-of-origin for perturbed-state fibroblasts in breast cancer

How cancer-associated fibroblasts promote T-cell exclusion in human lung tumors: a physical perspective

Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts

Cancer-Associated Fibroblasts: Major Co-Conspirators in Tumor Development

Clinical and therapeutic relevance of cancer-associated fibroblasts